Retension Pharmaceuticals, Inc.
RTSN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002002988
In the last 90 days, Retension Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
No financial statements
Retension Pharmaceuticals, Inc. has no financial statements on Livermore. They come from the XBRL data in 10-K, 10-Q, 20-F and 40-F filings, so ETFs, funds and companies that don't file these reports have none.